Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385715345> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4385715345 abstract "Sprue-like enteropathy (SE) related to olmesartan use was first reported in 2012. In 2017, the manufacturer of Benicar paid $300 million for 2300 claims for olmesartan-related SE.A study in 2019 suggested that SE was related to olmesartan and with the possibility of angiotensin receptor blocker (ARB) class effect. To further characterize this condition, our group examined reports of ARB-related SE to Food and Drug Administration Adverse Event Reporting System (FAERS).All reports of ARB-related SE from January 2017 to December 2021 were downloaded from the FAERS database. Gastrointestinal adverse events including SE were reviewed. Reporter categories included physicians, pharmacists, other health care professionals, consumers, and attorneys.A total of 106 590 reports of ARB-related adverse effects were analyzed. Sprue-like enteropathy was identified in 4337 cases (4.1% of total reports). Of these, 4240 cases (98.0%) of ARB-related SE were reported in patients using products with olmesartan, and 97 cases of SE were reported for all other ARBs (eprosartan, losartan, telmisartan, irbesartan, valsartan, and candesartan). Reports of olmesartan-related SE increased rapidly in 2017, continued at a high rate in 2018 and 2019, and essentially stopped in 2020 and 2021.Reports to FAERS for ARB-related SE are mostly related to olmesartan. There was a steep decline in reports of olmesartan-related SE following the lawsuit with potential of lawyer interference. There are reports of SE related to ARBs other than olmesartan, with increased physician awareness and the potential to discover a class effect with future studies." @default.
- W4385715345 created "2023-08-11" @default.
- W4385715345 creator A5012090116 @default.
- W4385715345 creator A5051915423 @default.
- W4385715345 creator A5069136704 @default.
- W4385715345 creator A5084255716 @default.
- W4385715345 creator A5088226977 @default.
- W4385715345 date "2023-08-09" @default.
- W4385715345 modified "2023-09-27" @default.
- W4385715345 title "Angiotensin Receptor Blocker–Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System" @default.
- W4385715345 cites W2005398267 @default.
- W4385715345 cites W2031806468 @default.
- W4385715345 cites W2034717895 @default.
- W4385715345 cites W2119401850 @default.
- W4385715345 cites W2166116295 @default.
- W4385715345 cites W2265643744 @default.
- W4385715345 cites W2290927540 @default.
- W4385715345 cites W2333346401 @default.
- W4385715345 cites W2608364534 @default.
- W4385715345 cites W2770399938 @default.
- W4385715345 cites W2793146560 @default.
- W4385715345 cites W2915365125 @default.
- W4385715345 cites W2948714489 @default.
- W4385715345 cites W2970683820 @default.
- W4385715345 cites W2986534514 @default.
- W4385715345 cites W3119973517 @default.
- W4385715345 doi "https://doi.org/10.1177/10600280231191834" @default.
- W4385715345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37559251" @default.
- W4385715345 hasPublicationYear "2023" @default.
- W4385715345 type Work @default.
- W4385715345 citedByCount "0" @default.
- W4385715345 crossrefType "journal-article" @default.
- W4385715345 hasAuthorship W4385715345A5012090116 @default.
- W4385715345 hasAuthorship W4385715345A5051915423 @default.
- W4385715345 hasAuthorship W4385715345A5069136704 @default.
- W4385715345 hasAuthorship W4385715345A5084255716 @default.
- W4385715345 hasAuthorship W4385715345A5088226977 @default.
- W4385715345 hasConcept C104849204 @default.
- W4385715345 hasConcept C104863432 @default.
- W4385715345 hasConcept C126322002 @default.
- W4385715345 hasConcept C170493617 @default.
- W4385715345 hasConcept C197934379 @default.
- W4385715345 hasConcept C2777105317 @default.
- W4385715345 hasConcept C2777387769 @default.
- W4385715345 hasConcept C2779766728 @default.
- W4385715345 hasConcept C2908929049 @default.
- W4385715345 hasConcept C512399662 @default.
- W4385715345 hasConcept C71924100 @default.
- W4385715345 hasConcept C84393581 @default.
- W4385715345 hasConcept C98274493 @default.
- W4385715345 hasConceptScore W4385715345C104849204 @default.
- W4385715345 hasConceptScore W4385715345C104863432 @default.
- W4385715345 hasConceptScore W4385715345C126322002 @default.
- W4385715345 hasConceptScore W4385715345C170493617 @default.
- W4385715345 hasConceptScore W4385715345C197934379 @default.
- W4385715345 hasConceptScore W4385715345C2777105317 @default.
- W4385715345 hasConceptScore W4385715345C2777387769 @default.
- W4385715345 hasConceptScore W4385715345C2779766728 @default.
- W4385715345 hasConceptScore W4385715345C2908929049 @default.
- W4385715345 hasConceptScore W4385715345C512399662 @default.
- W4385715345 hasConceptScore W4385715345C71924100 @default.
- W4385715345 hasConceptScore W4385715345C84393581 @default.
- W4385715345 hasConceptScore W4385715345C98274493 @default.
- W4385715345 hasLocation W43857153451 @default.
- W4385715345 hasLocation W43857153452 @default.
- W4385715345 hasOpenAccess W4385715345 @default.
- W4385715345 hasPrimaryLocation W43857153451 @default.
- W4385715345 hasRelatedWork W1199040258 @default.
- W4385715345 hasRelatedWork W1506481862 @default.
- W4385715345 hasRelatedWork W1983010996 @default.
- W4385715345 hasRelatedWork W1998396678 @default.
- W4385715345 hasRelatedWork W2012498986 @default.
- W4385715345 hasRelatedWork W2097957153 @default.
- W4385715345 hasRelatedWork W2117787550 @default.
- W4385715345 hasRelatedWork W2355305765 @default.
- W4385715345 hasRelatedWork W2467060920 @default.
- W4385715345 hasRelatedWork W4385715345 @default.
- W4385715345 isParatext "false" @default.
- W4385715345 isRetracted "false" @default.
- W4385715345 workType "article" @default.